Editorial
Published on 15 Nov 2024
Editorial: Recent advances in radiotheranostics
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2024.1520778
- 233 views
Type at least 3 characters
28 articles
Articles
Brief Research Report
Published on 06 Nov 2024
Can ChatGPT help patients understand radiopharmaceutical extravasations?
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2024.1469487
- 536 views
Review
Published on 11 Oct 2024
Terbium sisters: current development status and upscaling opportunities
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2024.1472500
- 937 views
Original Research
Published on 11 Oct 2024
Copper-61 is an advantageous alternative to gallium-68 for PET imaging of somatostatin receptor-expressing tumors: a head-to-head comparative preclinical study
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2024.1481343
- 544 views
Case Report
Published on 05 Feb 2024
Case Report: Radiopharmaceutical extravasation, radiation paranoia, and chilling effect
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2024.1349527
- 1,384 views
Editorial
Published on 27 Nov 2023
Editorial: Prof. Frank Rösch's legacy in the radiopharmaceutical chemistry field
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1336481
- 718 views
Hypothesis and Theory
Published on 13 Oct 2023
Radiopharmaceutical administration practices—Are they best practice?
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1244660
- 2,482 views
- 1 citation
Original Research
Published on 20 Sep 2023
Radiolabeled iron oxide nanoparticles functionalized with PSMA/BN ligands for dual-targeting of prostate cancer
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1184309
- 1,437 views
Perspective
Published on 05 Sep 2023
To tell or not to tell … the patient about potential harm
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1258960
- 1,218 views
Opinion
Published on 31 Jul 2023
Critique and discussion of “Multicenter evaluation of frequency and impact of activity infiltration in PET imaging, including microscale modeling of skin-absorbed dose”
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1240162
- 727 views
- 1 citation
Mini Review
Published on 20 Jul 2023
Radiopharmaceutical extravasations: a twenty year mini-review
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1219202
- 1,297 views
- 1 citation
Original Research
Published on 04 May 2023
Development of brain-penetrable antibody radioligands for in vivo PET imaging of amyloid-β and tau
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1173693
- 2,313 views
- 2 citations
Perspective
Published on 21 Apr 2023
The decision to reimage following extravasation in diagnostic nuclear medicine
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1171918
- 1,817 views
- 1 citation
Hypothesis and Theory
Published on 07 Mar 2023
Active monitoring improves radiopharmaceutical administration quality
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1126029
- 1,114 views
- 1 citation
Perspective
Published on 27 Feb 2023
Transparency – a patient-centric view on radiopharmaceutical extravasations
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2023.1127692
- 2,088 views
Original Research
Published on 23 Nov 2022
Development and evaluation of an 18F-labeled nanobody to target SARS-CoV-2's spike protein
in Radiopharmacy and Radiochemistry
Frontiers in Nuclear Medicine
doi 10.3389/fnume.2022.1033697
- 1,980 views